Antihypertensive effects of low-dose azilsartan in clinical practice

Antihypertensive effects of low-dose azilsartan in clinical practice - Antihypertensive effects of azilsartan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009515

Enrollment

300

Registered

2012-12-31

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

10 mg per day of azilsartan 8 mg per day of candesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Japanese patients who are treated with 8 mg per day of candesartan for hypertension

Exclusion criteria

Exclusion criteria: - patients who have been hypersensitive to candesartan or azilsartan - pregnant women and women suspected of being pregnant

Design outcomes

Primary

Measure	Time frame
blood pressure	—

Secondary

Measure	Time frame
albuminurea in patients with diabetes	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026